Here, Dr Laura McDonald and Dr Sreeram Ramagopalan, co-authors of an article published in BMC Medicine, comment on the implications of the closure of… Read more »
Health and healthcare were a prominent theme of this year’s World Economic Forum in Davos, and one of the first sessions took a look into our… Read more »
“It is difficult to make informed decisions if publication bias and selective reporting are present” World Health Organization… Read more »
It’s not often that I can claim to get excited about technology, but it’s hard not to after attending the Health 2.0 europe… Read more »
The AllTrials campaign (explained in a recent interview in our online magazine Biome) and books such as Ben Goldacre’s Bad… Read more »
In contrast to comparative research, case studies are individual reports related to the care and management of individual… Read more »
“Industry and academics must share all trial results: without this information, doctors are misled, and patients are… Read more »
BioMed Central in collaboration with an Ottawa-based researcher has received the Committee on Publication Ethics (COPE) research… Read more »
A new Current Controlled Trials (CCT) advisory board has been appointed as of October 2012, whom we are looking forward to working… Read more »
Jian Tang and Renata Curty are carrying out a study which examines the academic influence of Journal of Negative Results in… Read more »